The NPS bought shares in Samsung BioLogics & SK Bio
By Kim, Jin-Gu | translator Choi HeeYoung
21.07.06 06:18:42
가나다라
0
It invested ₩800 billion in pharmaceutical bio shares during net selling of ₩24 trillion in first half of this year
he National Pension Service bought ₩590 billion in Samsung BioLogics shares and ₩260 billion in SK Bioscience shares
And The NPS sold a net ₩360 billion in Celltrion shares
The National Pension Service (NPS), the nation's largest institutional investor, significantly reduced its investment in the local stock market in the first half of last year. Investment in pharmaceutical bio stocks has rather increased.
Investments in Samsung BioLogics, SK Bioscience, and SK Biopharm were significant. It sold more than ₩300 billion in shares of Celltrion.
According to the KRX on the 5th, The NPS bought Samsung BioLogics shares worth ₩586.4 billion in the first half of this year. Not only pharmaceutical bio shares but also all stocks ranked first in net buying.
The NPS' stake in Samsung BioLogics rose 0.12%p to 5.10% at the end of June from 4.98% a
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)